New Two-Pronged attack tested against deadly brain cancer
NCT ID NCT07392957
Summary
This early-stage study is testing two new drugs, CTX-009 and CTX-471, for people whose aggressive brain cancer (glioblastoma) has returned after standard treatment. Researchers want to see if using CTX-009 alone or combined with CTX-471 is safe and can help control the tumor and help patients live longer. The study will enroll about 54 adults to find the best dose and check for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.